orienx010
Gene therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 27, 2017 (NCT04200040)
Timeline
Indications
Studied for
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04197882 | Phase 1 | May 27, 2019 | Chinese Academy of Medical Sciences |
| NCT04206358 | Phase 1 | May 13, 2019 | Chinese Academy of Medical Sciences |
| NCT04200040 | Phase 2 | Aug 27, 2017 | Chinese Academy of Medical Sciences, OrienGene Biotechnology Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 3 | 2 | 2 | 2017 |
| OrienGene Biotechnology Ltd. | For profit | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1